AMPH

AMPHASTAR PHARMACEUTICALS IN

AMPH·03209R103·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

AMPH (AMPHASTAR PHARMACEUTICALS IN) is held by 108 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($105.4M), DIMENSIONAL FUND ADVISORS LP ($46.5M), STATE STREET CORP ($33.1M). Net institutional sentiment: Mixed.

108
Holders
(6 Elite)
$489.1M
Total Value
43% (110)
Consensus
47 buying - 63 selling
13F: Insider & Congress: Updated regularly
AMPH

Smart Money Verdict

View all
Loading verdict
Held by 108 funds
6 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Dec 18, 2025 · Activists Jul 14, 2026 · Congress none

ActivistDimensional Fund Advisors LPDimensional Fund Advisors LP5.2%Jul 14, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
InsiderZRZhou RongSell $256KDec 17, 2025
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
5.2M(-3.6%)$105.4M0.0%-40.16%
0
Increased
2.3M(+13.7%)$46.5M0.0%-28.45%
33
Increased
1.6M(+2.1%)$33.1M0.0%-61.12%
29
Decreased
1.5M(-4.0%)$29.9M0.0%+11.04%
0
Increased
1.2M(+15.6%)$23.7M0.0%-19.99%
33
Increased
1.1M(+4.0%)$21.5M0.0%-34.96%
30
Decreased
969,840(-0.7%)$19.6M0.0%-12.91%
0
Decreased
949,238(-32.0%)$19.2M0.1%-31.16%
0
Increased
887,048(+33.3%)$17.9M0.0%-6.80%
36
Increased
809,568(+2.8%)$16.3M0.0%+10.99%
29
Decreased
525,100(-5.2%)$10.6M0.0%-27.13%
0
Increased
505,360(+53.4%)$10.2M0.0%-19.65%
39
Increased
434,840(+3.5%)$8.8M0.0%-38.57%
29
Decreased
393,110(-6.5%)$7.9M0.0%-16.85%
0
Decreased
370,991(-0.3%)$7.5M0.0%-23.19%
0
Decreased
310,178(-3.4%)$6.3M0.0%-18.76%
0
Decreased
294,758(-27.4%)$5.9M0.0%-17.80%
0
Increased
248,115(+79.6%)$5M0.0%-22.96%
41
Increased
246,951(+64.0%)$5M0.0%-7.07%
39
Decreased
232,343(-4.5%)$4.7M0.0%-4.19%
0

Showing 1-20 of 123

1 / 7
AMPHAMPHAMPHASTAR PHARMACEUTICALS IN

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used